{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:50:24Z","timestamp":1759042224620},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.schres.2010.06.005","type":"journal-article","created":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T08:49:38Z","timestamp":1278492578000},"page":"86-90","source":"Crossref","is-referenced-by-count":11,"title":["Determining rates of hepatitis C in a clozapine treated cohort"],"prefix":"10.1016","volume":"124","author":[{"given":"Sanjeev","family":"Sockalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chekkera","family":"Shammi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2010.06.005_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/appi.psy.44.5.439","article-title":"Prevalence of hepatitis C in psychiatric institutions","volume":"44","author":"Al Jurdi","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2010.06.005_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.schres.2010.06.005_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1572-0241.2005.41860.x","article-title":"Prospective multicenter study of eligibility for antiviral therapy among 4, 084 U.S. veterans with chronic hepatitis C virus infection","volume":"100","author":"Bini","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.schres.2010.06.005_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0033-3182(09)70848-5","article-title":"Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: case study and literature review","volume":"50","author":"Cheng","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2010.06.005_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review","volume":"157","author":"Dieperink","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.06.005_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.160.1.172","article-title":"Prevalence of hepatitis C among psychiatric patients in the public sector","volume":"160","author":"Dinwiddie","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2010.06.005_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ps.54.6.836","article-title":"Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness","volume":"54","author":"Essock","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2010.06.005_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ps.54.6.836","article-title":"Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness","volume":"54","author":"Essock","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2010.06.005_bib9","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s10620-006-9669-0","article-title":"High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities","volume":"52","author":"Evon","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.schres.2010.06.005_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.schres.2010.06.005_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/appi.psy.48.5.405","article-title":"Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort","volume":"48","author":"Freudenreich","year":"2007","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.schres.2010.06.005_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1176\/appi.psy.50.1.30","article-title":"Understanding associations between serious mental illness and hepatitis C among veterans: a national multivariate analysis","volume":"50","author":"Himelhoch","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2010.06.005_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1440-1819.2000.00754.x","article-title":"Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis","volume":"54","author":"Hosoda","year":"2000","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2010.06.005_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3851\/IMP1493","article-title":"The influence of antiviral therapy on psychiatric symtoms among patients with hepatitis C and schizophrenia","volume":"15","author":"Huckans","year":"2010","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.schres.2010.06.005_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/schbul\/sbn065","article-title":"Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia","volume":"36","author":"Huckans","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.06.005_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1572-0241.1998.225_a.x","article-title":"Hepatitis C virus and depression in drug users","volume":"93","author":"Johnson","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.schres.2010.06.005_bib17","first-page":"270","article-title":"Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting","volume":"29","author":"Kerr","year":"2009","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.schres.2010.06.005_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.psy.49.1.86-a","article-title":"Treatment of hepatitis C with interferon-alpha and ribavirine in a patient with long-term clozapine treatment","volume":"49","author":"Liukkonen","year":"2008","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2010.06.005_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2007.00472.x","article-title":"Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders","volume":"10","author":"Matthews","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.schres.2010.06.005_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pnpbp.2004.01.018","article-title":"High prevalence of the hepatitis C infection among the inpatients of schizophrenia and psychoactive sbstance abuse in Japan","volume":"28","author":"Nakamura","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2010.06.005_bib21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1176\/appi.ps.56.12.1614","article-title":"Screening for infectious diseases among patients in a state psychiatric hospital","volume":"56","author":"Pirl","year":"2005","journal-title":"Psychiatr. Serv."},{"issue":"2","key":"10.1016\/j.schres.2010.06.005_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.addbeh.2009.09.012","article-title":"Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence","volume":"35","author":"Plebani","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.schres.2010.06.005_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/appi.ps.55.6.660","article-title":"The STIRR model of best practices for blood-borne diseases among clients with serious mental illness","volume":"55","author":"Rosenberg","year":"2004","journal-title":"Psychiatr. Serv."},{"issue":"1","key":"10.1016\/j.schres.2010.06.005_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.schres.2010.06.005_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1176\/ps.2009.60.4.534","article-title":"Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients","volume":"60","author":"Rothbard","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2010.06.005_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Screening Test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2010.06.005_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.21791","article-title":"Hepatitis C treatment in \"difficult-to-treat\" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects","volume":"46","author":"Schaefer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.schres.2010.06.005_bib28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.schres.2010.06.005_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.jcp.0000227348.59912.5d","article-title":"Persistent psychosis after treatment with interferon alfa: a case report","volume":"26","author":"Telio","year":"2006","journal-title":"J Clin. Psychopharmocol."},{"issue":"3","key":"10.1016\/j.schres.2010.06.005_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0924-9338(03)00032-4","article-title":"Acute psychosis after injection of pegylated interferon alpha-2a","volume":"18","author":"Thome","year":"2003","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2010.06.005_bib31","first-page":"165","article-title":"Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness","volume":"7","author":"Van Thiel","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.schres.2010.06.005_bib32","first-page":"341","article-title":"Hepatitis C: global prevalence","volume":"72","author":"WHO","year":"1997","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.schres.2010.06.005_bib33","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/BF03405100","article-title":"Current status of hepatitis C in Canada","volume":"91","author":"Zou","year":"2000","journal-title":"Can. J. Public Health"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410013605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410013605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T17:58:39Z","timestamp":1591466319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996410013605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0920996410013605"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2010.06.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}